- Imatinib (glivec) in the Treatment of patients with CML in accelerated phase and Ph+ ALL2003 | First Faculty of Medicine
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University
- Imatinib (glivec) in the Treatment of patients with CML in accelerated phase and Ph+ ALL2003 | Faculty of Medicine in Hradec Králové
- Comments to the study Dasatinib 140 mg once daily vs dasatinib 70 mg bid in patients with CML in accelerated phase +12009 | Publication without faculty affiliation
- The Kinetics of BCR-ABL Transcript Levels in CML Patients in Chronic ar Accelerated Phase during Imatinib Mesylate TreatmentPublication without faculty affiliation
- Imatinib (Glivec) in the treatment of patients with accelerated phase of chronic myelogenous leukaemia and Ph-positive acute lymphoblastic leukemia2003 | First Faculty of Medicine
- Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study2020 | Second Faculty of Medicine
- Prognosis of pediatric patients transplanted for Ph plus chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic2008 | First Faculty of Medicine
- Means of Stimulating the Player´s speed Preconditions (Speed-training system)2010 | Faculty of Physical Education and Sport
- Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with Imatinib mesylate for chronic or accelerated disease phase2004 | Publication without faculty affiliation
- Themes for track and field (athletics) in school (part III.) : Preparation for Reaction, Acceleration and Drive Phase2021 | Faculty of Physical Education and Sport
- Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia2006 | Third Faculty of Medicine
- Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial2018 | Second Faculty of Medicine
- Hsp90-a potential prognostic marker in CML2013 | Faculty of Science
- Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry2021 | Second Faculty of Medicine
- Analysis Of 180 Degree Turn Strategies In Elite Soccer PlayersPublication without faculty affiliation
- Allogeneic haematopoietic stem cell transplantation in patients with CML in Czech Republic, retrospective analysis of results from peroid 1988-20052006 | Second Faculty of Medicine
- Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial2018 | Publication without faculty affiliation